SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-028870
Filing Date
2024-07-24
Accepted
2024-07-24 08:36:15
Documents
17
Period of Report
2024-07-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50579
2 ex99-1.htm EX-99.1 24308
3 ex99-2.htm EX-99.2 38989
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3900
5 ex99-2_001.jpg GRAPHIC 17279
  Complete submission text file 0001493152-24-028870.txt   337728

Data Files

Seq Description Document Type Size
6 sonn-20240724.xsd EX-101.SCH 3018
7 sonn-20240724_lab.xml EX-101.LAB 34240
8 sonn-20240724_pre.xml EX-101.PRE 22361
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3710
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 241136248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)